Utang jangka cendhak marang modal: Myomo (MYO)

myomo.com - logo grafis emiten MYO

Myomo, Inc. (MYO) business development relies on physician recognition of robotic systems and the expansion of insurance coverage. Production is based on a combination of outsourcing electronics with final assembly at its own facilities. The price action on GURU.Markets, where the indicator is 0.28, confirms high margins driven by the exclusivity of myoelectric devices and the competition for government subsidies.

MYO - Koefisien utang jangka cendhak marang modal Myomo Inc. ing rentang 04.07.2022 - 31.10.2026
Produk mawa merek myomo.com

Myomo, Inc. (MYO) is developing a unique ecosystem of myoelectric robotics, creating vital rehabilitation tools for patients with paralysis. The current value of 0.28 reflects the share of short-term liabilities within the capital structure, where an increasing ratio of current loans to equity signals either the mobilization of resources for expansion or a risk of liquidity loss during debt servicing.

Analisis pesaing Myomo, Inc.

Utang jangka cendhak marang modal BSX|EW - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang modal RMD (ResMed Inc.)|PODD - Rasio utang jangka cendhak marang ekuitas|Zimmer Biomet Holdings - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal The Cooper Companies, Inc. COO|ALGN: Utang jangka cendhak marang modal|NuVasive (GMED) - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas TransMedics Group Inc|Utang jangka cendhak marang ekuitas ATEC|Utang jangka cendhak marang modal AORT|Koefisien utang jangka cendhak marang modal Enovis Corp|Integra - Rasio utang jangka cendhak marang ekuitas|ESTA (Establishment Labs Inc) - Kewajiban jangka cendhak marang ekuitas|Beta Bionics Inc - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal iradimed.com|EMBC: Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang modal TNDM|Rasio utang jangka cendhak marang ekuitas AXGN|SIBN: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Orthofix Medical Inc. (OFIX)|Rasio utang jangka cendhak marang ekuitas bioventus.com BVS|Utang jangka cendhak marang modal KIDS (OrthoPediatrics)|Treace Medical Concepts Inc (TMCI) - Kewajiban jangka cendhak marang modal|Strata Critical Medical Corp - Utang jangka cendhak marang modal|CARL (Carlsmed Medical) - Rasio utang jangka cendhak marang modal|RXST: Utang jangka cendhak marang modal|CLPT - Koefisien utang jangka cendhak marang modal|STXS (Stereotaxis) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas Neuronetics Inc. (STIM)|Utang jangka cendhak marang modal SGHT|Utang jangka cendhak marang modal orchestrabiomed.com (OBIO)|Utang jangka cendhak marang ekuitas Anika Therapeutics, Inc. ANIK|inspiremd.com - Utang jangka cendhak marang ekuitas|ZJYL: Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal VANI (Vivani Medical, Inc.)|XTNT: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal NeuroOne Medical Technologies Corp. (NMTC)|Utang jangka cendhak marang ekuitas Modular Medical Inc|COCH - Tanggungan utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas VVOS (Vivos Therapeutics, Inc.)|Utang jangka cendhak marang modal enVVeno Medical Corporation (NVNO)|Utang jangka cendhak marang modal SINT (Sintx Technologies, Inc.)|Koefisien utang jangka cendhak marang modal Tenon Medical Inc (TNON)|LFWD - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang ekuitas AMIX|INVO Fertility (IVF) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang ekuitas Bone Biologics Corp.|AXNX (Axonics Modulation Technologies) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Biolase Inc. BIOL|Utang jangka cendhak marang ekuitas Dynatronics Corporation (DYNT)|paragon28.com - Rasio utang jangka cendhak marang modal|INVO Bioscience - Rasio utang jangka cendhak marang ekuitas